Fig. 1From: Radiotherapy dose–volume parameters predict facial lymphedema after concurrent chemoradiation for nasopharyngeal carcinomaAveraged dose–volume histograms for patients with (solid) and without (dashed) facial lymphedema (grade ≥ 2)Back to article page